RGIN (Regenicin) Cyclically Adjusted Book per Share: $-0.02 (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Regenicin Cyclically Adjusted Book per Share?

Regenicin RGIN -99.00% Cyclically Adjusted Book per Share is $-0.02 as of Mar. 2023.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Regenicin's adjusted book value per share for the three months ended in Mar. 2023 was $-0.040. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.02 for the trailing ten years ended in Mar. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-02), Regenicin's current stock price is $0.0001. Regenicin's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was $-0.02. Regenicin's Cyclically Adjusted PB Ratio of today is .


Regenicin  (OTCPK:RGIN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Regenicin Cyclically Adjusted Book per Share Related Terms


Regenicin Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Regenicin's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenicin Cyclically Adjusted Book per Share Chart

Regenicin Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.02 -0.02

Regenicin Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.02 -0.02 -0.02

RGIN vs NOVNQ, TMBRQ, RGRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Regenicin's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenicin Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenicin's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regenicin's Cyclically Adjusted PB Ratio falls into.



Regenicin Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Regenicin's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book= Book Value per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.04/301.8360*301.8360
=-0.040

Current CPI (Mar. 2023) = 301.8360.

Regenicin Quarterly Data

Book Value per Share CPI Adj_Book
201306 -0.011 233.504 -0.014
201309 -0.036 234.149 -0.046
201312 -0.033 233.049 -0.043
201403 -0.033 236.293 -0.042
201406 -0.034 238.343 -0.043
201409 -0.011 238.031 -0.014
201412 0.005 234.812 0.006
201503 0.008 236.119 0.010
201506 0.005 238.638 0.006
201509 -0.003 237.945 -0.004
201512 -0.008 236.525 -0.010
201603 -0.011 238.132 -0.014
201606 -0.013 241.018 -0.016
201609 -0.010 241.428 -0.013
201612 -0.011 241.432 -0.014
201703 -0.013 243.801 -0.016
201706 -0.015 244.955 -0.018
201709 -0.016 246.819 -0.020
201712 -0.017 246.524 -0.021
201803 -0.019 249.554 -0.023
201806 -0.020 251.989 -0.024
201809 -0.020 252.439 -0.024
201812 -0.021 251.233 -0.025
201903 -0.022 254.202 -0.026
201906 -0.023 256.143 -0.027
201909 -0.024 256.759 -0.028
201912 -0.026 256.974 -0.031
202003 -0.027 258.115 -0.032
202006 -0.028 257.797 -0.033
202009 -0.028 260.280 -0.032
202012 -0.029 260.474 -0.034
202103 -0.030 264.877 -0.034
202106 -0.032 271.696 -0.036
202109 -0.032 274.310 -0.035
202112 -0.033 278.802 -0.036
202203 -0.034 287.504 -0.036
202206 -0.035 296.311 -0.036
202209 -0.036 296.808 -0.037
202212 -0.038 296.797 -0.039
202303 -0.040 301.836 -0.040

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-0.02 mean?
Regenicin (RGIN) has a Cyclically Adjusted Book per Share of $-0.02 as of Mar. 2023. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Regenicin and its competitors.
Is Regenicin's Cyclically Adjusted Book per Share too high?
Regenicin's current Cyclically Adjusted Book per Share is $-0.02.
How does Regenicin's Cyclically Adjusted Book per Share compare to NOVNQ and TMBRQ?
Regenicin's Cyclically Adjusted Book per Share of $-0.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Regenicin and its competitors. Regenicin's current Cyclically Adjusted Book per Share is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenicin stock overvalued right now?
Regenicin (RGIN) has a current Cyclically Adjusted Book per Share of $-0.02. The current Cyclically Adjusted Book per Share is $-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Regenicin (RGIN), the current Cyclically Adjusted Book per Share is $-0.02 as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenicin Business Description

Address 10530 Discovery Drive, Las Vegas, NV, USA, 89135
Regenicin Inc is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Its skin substitute product candidate comprises of NovaDerm. NovaDerm is a multi-layered tissue-engineered living skin prepared by utilizing autologous (patient's own) skin cells. It is a graftable cultured epithelium skin substitute containing both epidermal and dermal components with a collagen base. The technology has been clinically tested in Hundreds of pediatric, catastrophic burn patients.